Dabomb Protein Biotech (ROCO:6578) Accounts Payable & Accrued Expense : NT$31.2 Mil (As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Dabomb Protein Biotech Accounts Payable & Accrued Expense?

Dabomb Protein Biotech's quarterly accounts payable & accrued expense increased from Sep. 2024 (NT$32.4 Mil) to Dec. 2024 (NT$56.5 Mil) but then declined from Dec. 2024 (NT$56.5 Mil) to Mar. 2025 (NT$31.2 Mil).

Dabomb Protein Biotech's annual accounts payable & accrued expense declined from Dec. 2022 (NT$52.5 Mil) to Dec. 2023 (NT$24.9 Mil) but then increased from Dec. 2023 (NT$24.9 Mil) to Dec. 2024 (NT$56.5 Mil).

Dabomb Protein Biotech Accounts Payable & Accrued Expense Historical Data

The historical data trend for Dabomb Protein Biotech's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dabomb Protein Biotech Accounts Payable & Accrued Expense Chart

Dabomb Protein Biotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

61.84

41.26

52.48

24.87

56.46

Dabomb Protein Biotech Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															33.93	77.25	32.36	56.46	31.24

Dabomb Protein Biotech Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Dabomb Protein Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Dabomb Protein Biotech Corp (ROCO:6578) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

52,Gungye 3rd Road, Annan District, Tainan, TWN, 709

Website

https://www.dabombprotein.com

Dabomb Protein Biotech Corp is engaged in the manufacture, wholesale, and sale of hydrolyzed soy protein. Its products include Plant protein, Antibiotics alternatives, Pet care, Core technology, and CDMO(ODM/OEM). It operates in a single segment engaged in the manufacture, wholesale and sales of hydrolysed soy protein. Geographically it operates in Malaysia, Taiwan, USA, China, Vietnam, and Others with majority of the revenue deriving from Vietnam.

Dabomb Protein Biotech Headlines

No Headlines